Form D · Biotechnology
MICROMET, INC.
Rockville, MD · CIK 0001131907
Offering snapshot reported Mar 12, 2012 · SEC filing
- Reported sold
- $175M Offering amount: $175M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 7, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 12, 2012 | Initial | $175,463,420 | No comparison | 1 | SEC filing |
| Dec 16, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Dec 16, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Oct 15, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jul 5, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jan 7, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-174770
Source: Form D, filed Mar 12, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Sean E Harper | Director, Executive |
| Jonathan M Peacock | Director, Executive |
| David J Scott | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
9201 Corporate Boulevard, Suite 400
Rockville, MD, 20850
Rockville, MD, 20850